Miss any of our Recent Precision Value & Health Events? Check out our April Events Calendar
Miss any of our recent Precision Value & Health events? Check out our monthly marketing activities calendar to catch up on-demand, and stay ahead of upcoming dates!
PRECISIONvalue Adds Oncology Practice Veteran Christy Banach to Elevate and Evolve Market-Leading Access Experience Team
Addition of a Key Access Stakeholder Will Provide Clients With Winning Strategies to Address Complex and Rapidly Changing Cost and Utilization Challenges
APRIL 14, 2021 – New York, NY – PRECISIONvalue, a Precision Value & Health team, today announced the further strategic expansion of its Access Experience Team (AET), a specialized group of former access decision markers, with the addition of Christy Banach. Christy’s deep oncology practice background bolsters Precison’s ability to futher drive strategic and implementation support related to real-time experiences being managed at the point of patient care within oncology practices. (more…)
Upcoming Conference: AMCP 2021 Virtual
Attending AMCP 2021? Check out two PRECISIONvalue poster presentations, as well as our virtual booth which will be featuring our new white paper “Engaging With Integrated Delivery Networks to Address the Social Determinants of Health”. While you’re there, don’t forget to schedule some time to speak with some of our experts!
(more…)
Conference Video: World EPA Congress
Congratulations to PRECISIONadvisor’s Richard Macaulay on presenting “The Future of Innovative Reimbursement for Cell and Gene Therapies” at World EPA Congress 2021.
(more…)
Upcoming Webinar: Healthcare Trends in 2021 — How New Clinical and Scientific Innovations Are Shifting the Paradigm
In the first part of our Trends webinar series, our experts discussed how this shift has facilitated novel collaboration between health systems, plans, and pharmaceutical manufacturers and has also led to many new opportunities–but how is the healthcare landscape responding? Join us on Wednesday, April 28 @ 12:00 PM, and learn how new clinical and scientific innovations are shifting the healthcare paradigm.
White Paper: Developing Advanced Therapies — Considerations for Internal Versus External Manufacturing
Due to their complexity and cost, developers of cell and gene therapies face unique manufacturing hurdles. Determining the right approach to manufacturing is crucial when bringing these advanced therapeutics from clinical to commercialization.
This white paper, based on a recent webinar co-sponsored by Precision for Medicine and Informa Pharma Intelligence, features the unique expertise of Erin Harris (Editor In Chief of Cell & Gene), David Carr (Director, PRECISIONadvisors), Tony Khoury (Executive Vice President, Project Farma), Janet Lambert (CEO, Alliance for Regenerative Medicine), and Alex Karnal (Partner and Managing Director, Deerfield Management).
NCCN 2021 Virtual Annual Conference
Congratulations to PRECISIONheor’s Meaghan Roach MPH, Caroline Huber MPH, Suepattra May-Slater MPH, PhD, and Isha Desai MPH on the successful presentation of their poster “A Qualitative Study Describing Oncology Practitioners’ Approaches to First-Line (1L) Treatment of Metastatic Urothelial Cancer (mUC) in the United States” at NCCN 2021.
White Paper: Engaging With Integrated Delivery Networks to Address the Social Determinants of Health
Increasingly, stakeholders across the healthcare continuum are recognizing the importance of social determinants of health (SDOH) on outcomes and quality of life.
In this white paper from Precision’s Maureen Hennessey, we use the results of a 2019 PRECISIONvalue survey and a subsequent 2020 post-onset of COVID-19 survey to evaluate perspectives on SDOH and assess the progress of programs to address SDOH.
Precision Value & Health Snaps Up Across Health
Precision Value & Health recently announced the acquisition of Across Health, a Belgium based consultancy specializing in omnichannel strategy within the life-sciences space. Precision’s Carolyn Morgan discusses how Across Health’s proprietary, market-leading Navigator365 product suite will help Precision turbocharge its omnichannel platforms and digital transformation offering.
Precision Value & Health Acquires Global Omnichannel Engagement Leader, Across Health
EU-based team brings a unique omnichannel optimization platform and digital transformation capabilities to leading life-sciences companies
BETHESDA, MD—March 24, 2021—Precision Value & Health, the industry leader for commercialization services for innovative life science companies, today announced that it has acquired Across Health. Across Health is a leading global omnichannel engagement consultancy focused on providing clients an analytical and evidence-based framework for commercial strategy, execution, and resource optimization. The company’s solutions are based around its proprietary, market-leading Navigator365 product suite, which more than 40 pharmaceutical companies rely on for omnichannel planning and resource allocation. The Across Health team is already working hand-in-hand with Precision’s medical communications, creative, and data sciences teams to offer analytically driven launch and commercialization programs across the product life cycle.